NanoString Technologies Inc (NASDAQ:NSTG)
| 15.92 Delayed Data As of 4:02pm ET |  +0.95 / +6.35%Today’s Change | 13.52 Today|||52-Week Range 70.40 | -62.30% Year-to-Date |
Latest NSTG News | Press Releases
| RA CAPITAL MANAGEMENT, L.P. Buys 4, Sells 1 in 1st Quarter May 18 / GuruFocus News - Paid Partner Content |
Today’s Trading
| Previous close | 14.97 |
| Today’s open | 14.91 |
| Day’s range | 14.54 - 16.14 |
| Volume | 70,705 |
| Average volume (3 months) | 759,436 |
| Market cap | $777.5M |
Data as of 4:02pm ET, 05/19/2022
Growth & Valuation
| Earnings growth (last year) | +9.66% |
| Earnings growth (this year) | -7.09% |
| Earnings growth (next 5 years) | 0.00% |
| Revenue growth (last year) | +23.67% |
| P/E ratio | NM |
| Price/Sales | 13.19 |
| Price/Book | 4.33 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| MRUSMerus NV | +0.46 | +2.91% |
| NKTRNektar Therapeutics | +0.09 | +2.36% |
| REPLReplimune Group Inc | +0.17 | +1.20% |
| CDMOAvid Bioservices Inc | +0.86 | +7.34% |
Data as of 4:03pm ET, 05/19/2022
Financials
| Next reporting date | August 9, 2022 |
| EPS forecast (this quarter) | -$0.71 |
| Annual revenue (last year) | $145.1M |
| Annual profit (last year) | -$115.3M |
| Net profit margin | -79.44% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Seattle, Washington |
Forecasts
